OC
ABBV icon

Optima Capital’s AbbVie ABBV Stock Holding History

Optima Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$414K Buy
1,645
+18
+1% +$3.87K 0.16% 108
2026
Q1 		$354K Buy
1,627
+5
+0.3% +$1.11K 0.16% 110
2025
Q4 		$371K Sell
1,622
-136
-8% -$31K 0.16% 105
2025
Q3 		$407K Buy
1,758
+20
+1% +$4.07K 0.2% 99
2025
Q2 		$323K Buy
1,738
+1
+0.1% +$186 0.17% 122
2025
Q1 		$364K Hold
1,737
– – 0.23% 96
2024
Q4 		$309K Buy
+1,737
New +$319K 0.21% 117

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Optima Capital's ABBV Position: Q2 2026 in Review

Optima Capital increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $3.87K and bringing the position to 1,645 shares worth $414K. The position accounts for 0.16% of the portfolio, ranked #108.

Optima Capital first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Optima Capital held 1,645 shares of AbbVie worth $414K as of Q2 2026.
  • Optima Capital bought 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.16% of Optima Capital's portfolio in Q2 2026, its #108 holding.
  • Optima Capital first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Optima Capital's 13F filing for Q2 2026, filed 24 Jul 2026.